BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

934 related articles for article (PubMed ID: 15712225)

  • 1. Cone cGMP-gated channel mutations and clinical findings in patients with achromatopsia, macular degeneration, and other hereditary cone diseases.
    Nishiguchi KM; Sandberg MA; Gorji N; Berson EL; Dryja TP
    Hum Mutat; 2005 Mar; 25(3):248-58. PubMed ID: 15712225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Compound heterozygous CNGA3 mutations (R436W, L633P) in a Japanese patient with congenital achromatopsia.
    Goto-Omoto S; Hayashi T; Gekka T; Kubo A; Takeuchi T; Kitahara K
    Vis Neurosci; 2006; 23(3-4):395-402. PubMed ID: 16961972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive analysis of the achromatopsia genes CNGA3 and CNGB3 in progressive cone dystrophy.
    Thiadens AA; Roosing S; Collin RW; van Moll-Ramirez N; van Lith-Verhoeven JJ; van Schooneveld MJ; den Hollander AI; van den Born LI; Hoyng CB; Cremers FP; Klaver CC
    Ophthalmology; 2010 Apr; 117(4):825-30.e1. PubMed ID: 20079539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and genetic features of Hungarian achromatopsia patients.
    Varsányi B; Wissinger B; Kohl S; Koeppen K; Farkas A
    Mol Vis; 2005 Nov; 11():996-1001. PubMed ID: 16319819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transmembrane S1 mutations in CNGA3 from achromatopsia 2 patients cause loss of function and impaired cellular trafficking of the cone CNG channel.
    Patel KA; Bartoli KM; Fandino RA; Ngatchou AN; Woch G; Carey J; Tanaka JC
    Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2282-90. PubMed ID: 15980212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disease-associated mutations in CNGB3 produce gain of function alterations in cone cyclic nucleotide-gated channels.
    Bright SR; Brown TE; Varnum MD
    Mol Vis; 2005 Dec; 11():1141-50. PubMed ID: 16379026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CNGB3 mutations account for 50% of all cases with autosomal recessive achromatopsia.
    Kohl S; Varsanyi B; Antunes GA; Baumann B; Hoyng CB; Jägle H; Rosenberg T; Kellner U; Lorenz B; Salati R; Jurklies B; Farkas A; Andreasson S; Weleber RG; Jacobson SG; Rudolph G; Castellan C; Dollfus H; Legius E; Anastasi M; Bitoun P; Lev D; Sieving PA; Munier FL; Zrenner E; Sharpe LT; Cremers FP; Wissinger B
    Eur J Hum Genet; 2005 Mar; 13(3):302-8. PubMed ID: 15657609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Total colourblindness is caused by mutations in the gene encoding the alpha-subunit of the cone photoreceptor cGMP-gated cation channel.
    Kohl S; Marx T; Giddings I; Jägle H; Jacobson SG; Apfelstedt-Sylla E; Zrenner E; Sharpe LT; Wissinger B
    Nat Genet; 1998 Jul; 19(3):257-9. PubMed ID: 9662398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progressive cone dystrophy associated with mutation in CNGB3.
    Michaelides M; Aligianis IA; Ainsworth JR; Good P; Mollon JD; Maher ER; Moore AT; Hunt DM
    Invest Ophthalmol Vis Sci; 2004 Jun; 45(6):1975-82. PubMed ID: 15161866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cone photoreceptor function loss-3, a novel mouse model of achromatopsia due to a mutation in Gnat2.
    Chang B; Dacey MS; Hawes NL; Hitchcock PF; Milam AH; Atmaca-Sonmez P; Nusinowitz S; Heckenlively JR
    Invest Ophthalmol Vis Sci; 2006 Nov; 47(11):5017-21. PubMed ID: 17065522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cone dystrophy with supernormal rod response is strictly associated with mutations in KCNV2.
    Wissinger B; Dangel S; Jägle H; Hansen L; Baumann B; Rudolph G; Wolf C; Bonin M; Koeppen K; Ladewig T; Kohl S; Zrenner E; Rosenberg T
    Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):751-7. PubMed ID: 18235024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CNGB3 achromatopsia with progressive loss of residual cone function and impaired rod-mediated function.
    Khan NW; Wissinger B; Kohl S; Sieving PA
    Invest Ophthalmol Vis Sci; 2007 Aug; 48(8):3864-71. PubMed ID: 17652762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oligocone trichromacy: clinical and molecular genetic investigations.
    Andersen MK; Christoffersen NL; Sander B; Edmund C; Larsen M; Grau T; Wissinger B; Kohl S; Rosenberg T
    Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):89-95. PubMed ID: 19797231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic basis of total colourblindness among the Pingelapese islanders.
    Sundin OH; Yang JM; Li Y; Zhu D; Hurd JN; Mitchell TN; Silva ED; Maumenee IH
    Nat Genet; 2000 Jul; 25(3):289-93. PubMed ID: 10888875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A frameshift insertion in the cone cyclic nucleotide gated cation channel causes complete achromatopsia in a consanguineous family from a rural isolate.
    Rojas CV; María LS; Santos JL; Cortés F; Alliende MA
    Eur J Hum Genet; 2002 Oct; 10(10):638-42. PubMed ID: 12357335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutation in the gene GUCA1A, encoding guanylate cyclase-activating protein 1, causes cone, cone-rod, and macular dystrophy.
    Michaelides M; Wilkie SE; Jenkins S; Holder GE; Hunt DM; Moore AT; Webster AR
    Ophthalmology; 2005 Aug; 112(8):1442-7. PubMed ID: 15953638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in CNGA3 impair trafficking or function of cone cyclic nucleotide-gated channels, resulting in achromatopsia.
    Reuter P; Koeppen K; Ladewig T; Kohl S; Baumann B; Wissinger B;
    Hum Mutat; 2008 Oct; 29(10):1228-36. PubMed ID: 18521937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variable retinal phenotypes caused by mutations in the X-linked photopigment gene array.
    Mizrahi-Meissonnier L; Merin S; Banin E; Sharon D
    Invest Ophthalmol Vis Sci; 2010 Aug; 51(8):3884-92. PubMed ID: 20220053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetics and Disease Expression in the CNGA3 Form of Achromatopsia: Steps on the Path to Gene Therapy.
    Zelinger L; Cideciyan AV; Kohl S; Schwartz SB; Rosenmann A; Eli D; Sumaroka A; Roman AJ; Luo X; Brown C; Rosin B; Blumenfeld A; Wissinger B; Jacobson SG; Banin E; Sharon D
    Ophthalmology; 2015 May; 122(5):997-1007. PubMed ID: 25616768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel KCNV2 mutations in cone dystrophy with supernormal rod electroretinogram.
    Ben Salah S; Kamei S; Sénéćhal A; Lopez S; Bazalgette C; Bazalgette C; Eliaou CM; Zanlonghi X; Hamel CP
    Am J Ophthalmol; 2008 Jun; 145(6):1099-106. PubMed ID: 18400204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.